Doyle Mittie (CIK 0001918845)

Latest company ownership

AVTX - Avalo Therapeutics, Inc.

Role: Chief Medical Officer

Shares held

234,000

Last filed at

Jul 16, 2024

Confidence Score

33.1

2025Q4

Confidence Score History

2025Q4 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 10, 2025	Dec 12, 2025	Avalo Therapeutics, Inc.	Chief Medical Officer	Sell	27.5	-1,013	-21.86%	✗	$4.2K